I-Mab (IMAB)
I-Mab Statistics
Share Statistics
I-Mab has 35.44M shares outstanding. The number of shares has increased by 5.81% in one year.
Shares Outstanding | 35.44M |
Shares Change (YoY) | 5.81% |
Shares Change (QoQ) | 5.81% |
Owned by Institutions (%) | 6.36% |
Shares Floating | 35.34M |
Failed to Deliver (FTD) Shares | 173 |
FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 591.16K, so 0.73% of the outstanding shares have been sold short.
Short Interest | 591.16K |
Short % of Shares Out | 0.73% |
Short % of Float | 0.54% |
Short Ratio (days to cover) | 1.11 |
Valuation Ratios
The PE ratio is -0.77 and the forward PE ratio is -1.56. I-Mab's PEG ratio is 0.02.
PE Ratio | -0.77 |
Forward PE | -1.56 |
PS Ratio | 40.58 |
Forward PS | 1.3 |
PB Ratio | 0.65 |
P/FCF Ratio | -0.85 |
PEG Ratio | 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for I-Mab.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.01.
Current Ratio | 5.67 |
Quick Ratio | 5.64 |
Debt / Equity | 0.01 |
Debt / EBITDA | -0.02 |
Debt / FCF | -0.01 |
Interest Coverage | -12135.2 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $125.65K |
Profits Per Employee | $-6.66M |
Employee Count | 220 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | -1.26B |
Effective Tax Rate | 85.89% |
Stock Price Statistics
The stock price has increased by -57.38% in the last 52 weeks. The beta is 1.15, so I-Mab's price volatility has been higher than the market average.
Beta | 1.15 |
52-Week Price Change | -57.38% |
50-Day Moving Average | 0.92 |
200-Day Moving Average | 1.14 |
Relative Strength Index (RSI) | 32.56 |
Average Volume (20 Days) | 316.68K |
Income Statement
In the last 12 months, I-Mab had revenue of 27.64M and earned -1.47B in profits. Earnings per share was -7.66.
Revenue | 27.64M |
Gross Profit | 27.64M |
Operating Income | -1.24B |
Net Income | -1.47B |
EBITDA | -1.21B |
EBIT | -206.67M |
Earnings Per Share (EPS) | -7.66 |
Balance Sheet
The company has 302.1M in cash and 18.89M in debt, giving a net cash position of 283.21M.
Cash & Cash Equivalents | 302.1M |
Total Debt | 18.89M |
Net Cash | 283.21M |
Retained Earnings | -8.33B |
Total Assets | 232.68M |
Working Capital | 176.44M |
Cash Flow
In the last 12 months, operating cash flow was -184.09M and capital expenditures -1.6M, giving a free cash flow of -1.32B.
Operating Cash Flow | -184.09M |
Capital Expenditures | -1.6M |
Free Cash Flow | -1.32B |
FCF Per Share | -6.88 |
Margins
Gross margin is 100%, with operating and profit margins of -4471.2% and -5302.03%.
Gross Margin | 100% |
Operating Margin | -4471.2% |
Pretax Margin | -5302.03% |
Profit Margin | -5302.03% |
EBITDA Margin | -4384.57% |
EBIT Margin | -4471.2% |
FCF Margin | -4761.62% |
Dividends & Yields
IMAB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for IMAB is $7, which is 797.4% higher than the current price. The consensus rating is "Buy".
Price Target | $7 |
Price Target Difference | 797.4% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Scores
Altman Z-Score | -11.38 |
Piotroski F-Score | 4 |